{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:07:02Z","timestamp":1740136022768,"version":"3.37.3"},"reference-count":7,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T00:00:00Z","timestamp":1617580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"PHRC and INCa 2012","award":["NCT01903967"],"award-info":[{"award-number":["NCT01903967"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,13]]},"DOI":"10.1210\/clinem\/dgab217","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T20:21:55Z","timestamp":1617740515000},"page":"e3285-e3286","source":"Crossref","is-referenced-by-count":0,"title":["Letter to the Editor From Helene Lasolle and G\u00e9rald Raverot: \u201cUSP8 and TP53 Drivers Are Associated With CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors\u201d"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5027-7660","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Lasolle","sequence":"first","affiliation":[{"name":"F\u00e9d\u00e9ration d\u2019Endocrinologie, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France"},{"name":"Universit\u00e9 Lyon 1, Lyon, France"},{"name":"INSERM U1052, CNRS UMR5286, Cancer Research Center of Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9517-338X","authenticated-orcid":false,"given":"G\u00e9rald","family":"Raverot","sequence":"additional","affiliation":[{"name":"F\u00e9d\u00e9ration d\u2019Endocrinologie, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France"},{"name":"Universit\u00e9 Lyon 1, Lyon, France"},{"name":"INSERM U1052, CNRS UMR5286, Cancer Research Center of Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2021,4,5]]},"reference":[{"issue":"1","key":"2021071319530239400_CIT0001","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol."},{"key":"2021071319530239400_CIT0002","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa853","article-title":"USP8 and TP53 drivers are associated with CNV in a corticotroph adenoma cohort enriched for aggressive tumors","author":"Uzilov","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021071319530239400_CIT0003","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/neuonc\/noz109","article-title":"Driver mutations in USP8 wild-type Cushing\u2019s disease","volume":"21","author":"Sbiera","year":"2019","journal-title":"Neuro-Oncol."},{"key":"2021071319530239400_CIT0004","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-01956","article-title":"Recurrence in silent corticotroph adenomas after primary treatment: A systematic review and meta-analysis","author":"Fountas","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021071319530239400_CIT0005","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1210\/jc.2017-00773","article-title":"Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification","volume":"102","author":"Raverot","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"journal-title":"Endocr Rev.","article-title":"Novel insights into pituitary tumorigenesis: genetic and epigenetic mechanisms","author":"Srirangam Nadhamuni","key":"2021071319530239400_CIT0006"},{"issue":"1","key":"2021071319530239400_CIT0007","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40478-020-01067-5","article-title":"Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis","volume":"8","author":"Lasolle","year":"2020","journal-title":"Acta Neuropathol Commun."}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab217\/38826609\/dgab217.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/106\/8\/e3285\/38939617\/dgab217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/106\/8\/e3285\/38939617\/dgab217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T19:54:33Z","timestamp":1626206073000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/8\/e3285\/6211055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,5]]},"references-count":7,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4,5]]},"published-print":{"date-parts":[[2021,7,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab217","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"type":"print","value":"0021-972X"},{"type":"electronic","value":"1945-7197"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,4,5]]}}}